Stephen D. Griffin

Stephen D. Griffin

President and Chief Executive Officer; Former EVP, Chief Financial Officer and Chief Operating OfficeratAnika Therapeutics· In proxies 2024–2025

Pay in FY2025-23% from the year before · Anika Therapeutics stock -41.6% the same year

Stephen D. Griffin was paid $2.0M in FY2025 (Dec), down 23%. Anika Therapeutics stock fell 41.6% that year.

Pay$100 in the stock at the end of FY23 → $42
Pay is from the Summary Compensation Table of each Anika Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Anika TherapeuticsPublic company · 2 yr
    • President and Chief Executive Officer; Former EVP, Chief Financial Officer and Chief Operating Officer2024 – Present · 2 yrStock in role -5%

Roles come from the proxy statements of each company.

Boards1

  • Anika TherapeuticsDirector · -1 yr on the boardNot independent—Paid as an executive

Board seats come from each company's latest proxy statement.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?